Edinburgh-based biotech company Cytomos has announced a significant milestone, raising $5m (approximately £3.98m) in an oversubscribed funding round to...
Read MoreCoca-Cola Europacific Partners (CCEP) is reinforcing its commitment to innovation and sustainability with a significant £42.3m investment in a...
Read MoreTeva Pharmaceuticals and Immunai, a leader in artificial intelligence (AI)-driven immune system mapping, have announced a groundbreaking multi-year partnership...
Read MorePremium spirits producer Gravity Drinks has secured a significant £4.5m finance package to support its growth ambitions and meet...
Read MoreOsivax, a pioneering biopharmaceutical company, has achieved a significant milestone by vaccinating the first participant in its Phase 2a...
Read MoreAC Immune SA has announced encouraging interim results from its ongoing Phase 2 VacSYn clinical trial of ACI-7104.056, an...
Read More